RSV ACIP Vaccine Recommendations
Advisory Committee on Immunization Practices (ACIP)
On This Page
Published in Morbidity and Mortality Weekly Report (MMWR)
The Advisory Committee on Immunization Practices (ACIP) provides advice and guidance to the Director of the CDC regarding use of vaccines and related agents for control of vaccine-preventable diseases in the civilian population of the United States. Recommendations made by the ACIP are reviewed by the CDC Director and, if adopted, are published as official CDC/HHS recommendations in the Morbidity and Mortality Weekly Report (MMWR).
CURRENT RSV Vaccine Recommendations
- MMWR; August 25, 2023 / 72(34);920–925
Use of Nirsevimab for the Prevention of Respiratory Syncytial Virus Disease Among Infants and Young Children: Recommendations of the Advisory Committee on Immunization Practices — United States, 2023
Print version [6 pages] See page 1. - MMWR; July 21, 2023;72(29);793–801
Use of Respiratory Syncytial Virus Vaccines in Older Adults: Recommendations of the Advisory Committee on Immunization Practices — United States, 2023
Print version [9 pages] See page 1.
ARCHIVED RSV Immunization Publications
For your convenience, these archived publications can be used for historical and research purposes.
- No archived articles at this time.